Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients

Clin Transl Med. 2021 Jun;11(6):e432. doi: 10.1002/ctm2.432.

Jianglan Long^{1

2

3}, Hui Yang⁴, Zhirui Yang^{1

3}, Qingquan Jia⁵, Liwei Liu⁵, Lingwei Kong⁶, Huijing Cui⁶, Suying Ding⁵, Qian Qin⁵, Nana Zhang⁷, Xingzhong Feng⁸, Shuxun Yan⁹, Jinfa Tang⁹, Shuo Chen¹⁰, Yumei Han¹⁰, Tao Jiang³, Zhen Wen³, Ningning Qi³, Kejun Deng⁴, Zhi Sun⁵, Hao Lin⁴, Dan Yan^{1

2}

¹ Beijing Friendship Hospital, Capital Medical University, Beijing, China.
² Beijing Key Laboratory for Evaluation of Rational Drug Use, Beijing, China.
³ Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
⁴ College of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
⁵ Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, China.
⁶ Beijing Jiaotong University Community Health Center, Beijing, China.
⁷ Department of Pharmacy, Kaifeng Hospital of Traditional Chinese Medicine, Kaifeng, Henan, China.
⁸ Department of Endocrinology and Immunology, Yuquan Hospital of Tsinghua University, Beijing, China.
⁹ Department of Endocrinology, The First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
¹⁰ Beijing Physical Examination Center, Beijing, China.

No abstract available

Publication types